Inify Laboratories announced to be on track in building its first ultramodern laboratory at Campus Solna, Sweden, next to world-leading healthcare. The company expects to move into the new facility during the fourth quarter of 2022 and to immediately commence installation of systems and equipment, followed by accreditation. The laboratory will begin production of prostate cancer diagnoses according to plan - sometime during the first half of 2023.